Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study
- PMID: 38879452
- PMCID: PMC11255739
- DOI: 10.1161/JAHA.124.035549
Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study
Abstract
Background: The incidental finding of a pericardial effusion (PE) poses a challenge in clinical care. PE is associated with malignant conditions or severe cardiac disease but may also be observed in healthy individuals. This study explored the prevalence, determinants, course, and prognostic relevance of PE in a population-based cohort.
Methods and results: The STAAB (Characteristics and Course of Heart Failure Stages A/B and Determinants of Progression) cohort study recruited a representative sample of the population of Würzburg, aged 30 to 79 years. Participants underwent quality-controlled transthoracic echocardiography including the dedicated evaluation of the pericardial space. Of 4965 individuals included at baseline (mean age, 55±12 years; 52% women), 134 (2.7%) exhibited an incidentally diagnosed PE (median diameter, 2.7 mm; quartiles, 2.0-4.1 mm). In multivariable logistic regression, lower body mass index and higher NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels were associated with PE at baseline, whereas inflammation, malignancy, and rheumatoid disease were not. Among the 3901 participants attending the follow-up examination after a median time of 34 (30-41) months, PE was found in 60 individuals (1.5%; n=18 new PE, n=42 persistent PE). Within the follow-up period, 37 participants died and 93 participants reported a newly diagnosed malignancy. The presence of PE did not predict all-cause death or the development of new malignancy.
Conclusions: Incidental PE was detected in about 3% of individuals, with the vast majority measuring <10 mm and completely resolving. PE was not associated with inflammation markers, death, incident heart failure, or malignancy. Our findings corroborate the view of current guidelines that a small PE in asymptomatic individuals can be considered an innocent phenomenon and does not require extensive short-term monitoring.
Keywords: incidental finding; pericardial effusion; population‐based cohort; prognostic relevance.
Figures
Similar articles
-
N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions.Korean J Intern Med. 2008 Jun;23(2):78-86. doi: 10.3904/kjim.2008.23.2.78. Korean J Intern Med. 2008. PMID: 18646510 Free PMC article.
-
The N-terminal pro-B-type natriuretic peptide as a predictor of disease progression in patients with pericardial effusion.Int J Cardiol. 2012 May 31;157(2):192-6. doi: 10.1016/j.ijcard.2010.12.009. Epub 2010 Dec 30. Int J Cardiol. 2012. PMID: 21194766
-
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).J Am Heart Assoc. 2018 Feb 3;7(3):e006740. doi: 10.1161/JAHA.117.006740. J Am Heart Assoc. 2018. PMID: 29431103 Free PMC article.
-
Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.Eur J Heart Fail. 2013 Aug;15(8):859-67. doi: 10.1093/eurjhf/hft048. Epub 2013 Apr 7. Eur J Heart Fail. 2013. PMID: 23568644
-
The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.Minerva Cardioangiol. 2016 Apr;64(2):157-64. Epub 2015 Sep 15. Minerva Cardioangiol. 2016. PMID: 26373781 Review.
Cited by
-
Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa.JACC Adv. 2024 Dec 5;4(1):101427. doi: 10.1016/j.jacadv.2024.101427. eCollection 2025 Jan. JACC Adv. 2024. PMID: 39720579 Free PMC article.
References
-
- Adler Y, Charron P, Imazio M, Badano L, Baron‐Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio‐Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–2964. doi: 10.1093/eurheartj/ehv318 - DOI - PMC - PubMed
-
- De Filippo O, Gatti P, Rettegno S, Iannaccone M, D'Ascenzo F, Lazaros G, Brucato A, Tousoulis D, Adler Y, Imazio M. Is pericardial effusion a negative prognostic marker? Meta‐analysis of outcomes of pericardial effusion. J Cardiovasc Med (Hagerstown). 2019;20:39–45. doi: 10.2459/JCM.0000000000000720 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials